Mittie Doyle, Chief Medical Officer: Avalo Therapeutics AVTX Planned sale · Filed 03/16

Trade details

Type: Planned sale notice
Stock: Avalo Therapeutics AVTX
Person: Mittie DoyleChief Medical Officer
Planned sale date: 26/03/16
Filed: 26/03/16

0.2% of shares outstanding to be sold

Avalo Therapeutics trades, last 26 weeks

What else happened in Avalo Therapeutics around then

Filed or reported within 30 days of the trade day · 02/14~04/15

Mittie Doyle's recent trades

Mittie DoyleChief Medical Officer
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$98.7K
5,037 sh
$98.7K
Filed 08/17
Traded 08/17
Mittie DoyleChief Medical Officer
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$12.4K
679 sh
$12.4K
Filed 08/10
Traded 08/10
Mittie DoyleChief Medical Officer
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$26.1K
1,450 sh
$26.1K
Filed 06/25
Traded 06/23
Mittie DoyleChief Medical Officer
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$10.9K
679 sh
$10.9K
Filed 06/01
Traded 05/28
Mittie DoyleChief Medical Officer
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$56.3K
3,000 sh
$56.3K
Filed 05/19
Traded 05/15

Mittie Doyle, Chief Officer — plans to sell 29,529 sh of Avalo Therapeutics AVTX · $466.6K · around 03/16 · 10b5-1 plan | Whalegun